Table 2 Fine-needle aspiration evaluation among thyroidectomy patients
From: The diagnostic role of FNA based on clinicopathological features in thyroid malignancy
Group | Fine Needle Aspiration Finding | Frequency (%); N = 310 |
|---|---|---|
Malignant | Papillary thyroid carcinoma | 142 (45.8) |
Medullar Carcinoma | 3 (1.0) | |
Poorly Differentiated Carcinoma | 2 (0.6) | |
Anaplastic Carcinoma | 1 (0.3) | |
Squamous Cell Carcinoma | 1 (0.3) | |
Non-Malignant | Adenomatous Goiter | 2 (0.6) |
Benign Follicular Nodule | 5 (1.6) | |
Colloid Goiter | 3 (1.0) | |
Multinodular Goiter | 93 (30.0) | |
Hashimoto | 1 (0.3) | |
Lymphocytic Thyroiditis | 1 (0.3) | |
Graves | 2 (0.6) | |
Indeterminate or mixed | Atypia of undetermined significance | 27 (8.7) |
Follicular Neoplasm | 10 (3.2) | |
Hurthle Cell change | 5 (1.6) | |
Neoplastic Nodule | 3 (1.0) | |
Multinodular Goiter + Hurthle Cell change | 3 (1.0) | |
Multinodular Goiter + Atypia of undetermined significance | 1 (0.3) | |
Atypical follicular lesion of undetermined significance | 1 (0.3) | |
Follicular Neoplasm + Atypia of undetermined significance + Hurthle cell change | 1 (0.3) | |
Follicular Neoplasm + Adenomatous Goiter | 1 (0.3) | |
Colloid Goiter + Lymphocytic thyroiditis | 1 (0.3) | |
Lymphocytic thyroiditis + Malignant change | 1 (0.3) | |
BSRTC category | Benign (II) | 108 (34.8) |
Atypia of undetermined significance (III) | 32 (10.3) | |
Follicular neoplasm (IV) | 20 (6.5) | |
Suspicious for malignancy (V) | 1 (0.3) | |
Malignant (VI) | 149 (48.1) |